C18H24I3N3O9
Neat
807.12
Room Temperature
104517-96-6; Ioversol related compound B; 1-N, 3-N-bis(2, 3-dihydroxypropyl)-5-[2-(2-hydroxyethylamino)-2-oxoethoxy]-2, 4, 6-triiodobenzene-1, 3-dicarboxamide; Ioversol Related Compound B (50 mg) (N, N'-bis(2, 3-dihydroxypropyl)-5-[(N-(2-hydroxyethyl)-carbamoyl)methoxy]-2, 4, 6-triiodoisophthalamide); N, N'-Bis(2, 3-dihydroxypropyl)-5-[(N-(2-hydroxyethyl)-carbamoyl)methoxy]-2, 4, 6-triiodoisophthalamide; N, N'-Bis(2, 3-dihydroxypropyl)-5-((N-(2-hydroxyethyl)-carbamoyl)methoxy)-2, 4, 6-triiodoisophthalamide; Ioversol Impurity 5; K8RN54FJV8; SCHEMBL8858996; Ioversol related compound B [USP IMPURITY]; F96739; 1, 3-Benzenedicarboxamide, N, N'-bis(2, 3-dihydroxypropyl)-5-[2-[(2-hydroxyethyl)amino]-2-oxoethoxy]-2, 4, 6-triiodo-; N, N'-Bis(2, 3-dihydroxypropyl)-5-{[N-(2-hydroxyethyl)amino]-2-oxoethoxy}-2, 4 and 6-triiodoisophthalamide
1-N, 3-N-bis(2, 3-dihydroxypropyl)-5-[2-(2-hydroxyethylamino)-2-oxoethoxy]-2, 4, 6-triiodobenzene-1 and 3-dicarboxamide
InChI=1S/C18H24I3N3O9/c19-13-11(17(31)23-3-8(28)5-26)14(20)16(33-7-10(30)22-1-2-25)15(21)12(13)18(32)24-4-9(29)6-27/h8-9,25-29H,1-7H2,(H,22,30)(H,23,31)(H,24,32)